NLRX1 increases human retinal pigment epithelial autophagy and reduces H2O2-induced oxidative stress and inflammation by suppressing FUNDC1 phosphorylation and NLRP3 activation

Main Article Content

Qian Wang
Fengying He
Liping Wu

Keywords

age-related macular degeneration, autophagy, FUNDC1, Inflammation, NLRX1, NLRP3, inflammasome, oxidative stress

Abstract

Background: Age-related macular degeneration (AMD) is a leading cause of impaired vision as well as some earlier effects, such as reading and face recognition. Oxidative damage and inflammation of retinal pigment epithelial (RPE) cells are major causes of AMD. Additionally, autophagy in RPE cells can lead to cellular homeostasis under oxidative stress. Nucleotide-binding oligomerization domain (NOD)-like receptor X1 (NLRX1) is a mysterious modulator of the immune system function which inhibits inflammatory response, attenuates reactive oxygen species (ROS) production, and regulates autophagy. This study attempted to explore the role of NLRX1 in oxidative stress, inflammation, and autophagy in AMD.


Methods: An in vitro model of AMD was built in human retinal pigment epithelial cell line 19 (ARPE-19) treated with H2O2. The cell viability, NLRX1 expressions, levels of superoxide dismutase (SOD), glutathione (GHS), and ROS, concentrations of interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), IL-6, and monocyte chemoattractant protein-1 (MCP-1), expressions of NLRX1, p62, LC3-II/LC3-I, FUNDC1, and NOD-like receptor protein 3 (NLRP3) inflammasome were expounded by cell counting kit-8, colorimetric, enzyme-linked immunosorbent serologic assay (ELISA), and Western blot assay.


Results: H2O2 treatment notably reduced the relative protein expression of NLRX1. Meanwhile, H2O2 incubation decreased cell viability, diminished SOD and GSH concentrations, accompanied with the increased level of ROS, enhanced IL-1β, TNF-α, IL-6, and MCP-1 concentrations, and aggrandized the relative protein expression of p62 with reduced LC3-II/LC3-I ratio. Moreover, these results were further promoted with knockdown of NLRX1 and reversed with overexpression. Mechanically, silencing of NLRX1 further observably enhanced the relative levels of -phosphorylated FUNDC1/FUNDC1, and NLRP3 inflammasome-related proteins, while overexpression of NLRX1 exhibited inverse results in the H2O2-induced ARPE-19 cells.


Conclusion: NLRX1 suppressed H2O2-induced oxidative stress and inflammation, and facilitated autophagy by suppressing FUNDC1 phosphorylation and NLRP3 activation in ARPE-19 cells.

Abstract 115 | PDF Downloads 113 HTML Downloads 12 XML Downloads 2

References

1. Arruabarrena C, Toro MD, Onen M, Malyugin BE, Rejdak R, Tognetto D, et al. Impact on visual acuity in neovascular age related macular degeneration (nAMD) in Europe due to COVID-19 pandemic lockdown. J Clin Med. 2021;10(15):. 10.3390/jcm10153281.

2. Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, et al. Age-related macular degeneration. Nat Rev Dis Primers. 2021;7(1):31. 10.1038/s41572-021-00265-2.

3. Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–59. 10.1016/s0140-6736(18)31550-2.

4. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144–60. 10.1016/s2214-109x(20)30489-7.

5. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16. 10.1016/s2214-109x(13)70145-1.

6. Zhang ZY, Bao XL, Cong YY, Fan B, Li GY. Autophagy in age--related macular degeneration: A regulatory mechanism of oxidative stress. Oxid Med Cell Longev. 2020;2020:2896036. 10.1155/2020/2896036.

7. Kourelis J, Adachi H. Activation and regulation of NLR immune receptor networks. Plant Cell Physiol. 2022. Epub ahead of print. 10.1093/pcp/pcac116.

8. Li H, Zhang S, Li F, Qin L. NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation. Mol Immunol.2016;76:90–7. 10.1016/j.molimm.2016.06.013.

9. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, et al. NLRX1 negatively regulates TLR-induced NF-κB signaling by targeting TRAF6 and IKK. immunity. 2011;34(6):843–53. 10.1016/j.immuni.2011.02.022. PMid: 21703539.

10. Nagai-Singer MA, Morrison HA, Allen IC. NLRX1 is a multifaceted and enigmatic regulator of immune system function. Front Immunol. 2019;10:2419. 10.3389/fimmu.2019.02419.

11. Leber A, Hontecillas R, Tubau-Juni N, Zoccoli-Rodriguez V, Abedi V, Bassaganya-Riera J. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease. Front Immunol. 2018; 9:363. 10.3389/fimmu.2018.00363.PMid: 29535731.

12. Shi H, Zhou ZM, Zhu L, Chen L, Jiang ZL, Wu XT. Underlying Mechanisms and Related Diseases Behind the Complex Regulatory Role of NOD-Like Receptor X1. DNA Cell Biol. 2022; 41(5):469-478. 10.1089/dna.2022.0051. PMid: 35363060.

13. Li S, Zhou Y, Gu X, Zhang X, Jia Z. NLRX1/FUNDC1/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury. Cell Prolif. 2021;54(3):e12986. 10.1111/cpr.12986.

14. Lim Y, Rubio-Peña K, Sobraske PJ, Molina PA, Brookes PS, Galy V, Nehrke et al. Fndc-1 contributes to paternal mitochondria elimination in C. elegans. Dev Biol. 2019;454(1):15–20. 10.1016/j.ydbio.2019.06.016.

15. Liu L, Sakakibara K, Chen Q, Okamoto K. Receptor-mediated mitophagy in yeast and mammalian systems. Cell Res. 2014; 24(7):787–95. 10.1038/cr.2014.75.

16. Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78(8):3817–51. 10.1007/s00018-021-03774-1.

17. Liu L, Feng D, Chen G, Chen M, Zheng Q, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol. 2012;14(2):177–85. 10.1038/ncb2422.

18. Pan P, Chen J, Liu X, Fan J, Zhang D, Zhao W, et al. FUNDC1 regulates autophagy by inhibiting ROS-NLRP3 signaling to avoid apoptosis in the lung in a lipopolysaccharide-induced mouse model. Shock. 2021; 56(5):773–81. 10.1097/shk.0000000000001835..

19. Chang CC, Huang TY, Chen HY, Huang TC, Lin LC, Chang YJ, et al. Protective effect of melatonin against oxidative stress-induced apoptosis and enhanced autophagy in human retinal pigment epithelium cells. Oxid Med Cell Longev. 2018;2018:9015765. 10.1155/2018/9015765.

20. Chhabra R, Rao S, Kumar BM, Shetty AV, Hegde AM, Bhandary M. Characterization of stem cells from human exfoliated deciduous anterior teeth with varying levels of root resorption. J Clin Pediat Dentistry. 2021;45(2):104–11. 10.17796/1053-4625-45.2.6.

21. Fu Y, Jin R-R, Li Y-L, Luan H, Huang T, Zhao Y, et al. Isocorydine inhibits the proliferation of human endometrial carcinoma HEC-1B cells by downregulating the Ras/MEK/ERK signaling pathway. EJGO. 2021;42(3):548–53. 10.31083/j.ejgo.2021.03.5225.

22. Song C, Adili A, Kari A, Abuduhaer A. FSTL1 aggravates sepsis--induced acute kidney injury through regulating TLR4/MyD88/NF-κB pathway in newborn rats. Signa Vitae. 2021;17(3): 167–73. 10.22514/sv.2021.071.

23. Zhou H, Li D, Zhu P, Hu S, Hu N, Ma S, et al. Melatonin suppresses platelet activation and function against cardiac ischemia/reperfusion injury via PPARγ/FUNDC1/mitophagy pathways. J Pineal Res. 2017; 63(4):e12438. 10.1111/jpi.12438.

24. Morrison HA, Liu Y, Eden K, Nagai-Singer MA, Wade PA, Allen IC. NLRX1 deficiency alters the gut microbiome and is further exacerbated by adherence to a gluten-free diet. Front Immunol. 2022;13:882521. 10.3389/fimmu.2022.882521.

25. Pickering RJ, Booty LM. NLR in eXile: Emerging roles of NLRX1 in immunity and human disease. Immunology. 2021;162(3):268–80. 10.1111/imm.13291.

26. Yang Y, Yang X, Wu Y, Fu M. METTL3 promotes inflammation and cell apoptosis in a pediatric pneumonia model by regulating EZH2. Allergol Immunopathol (Madr). 2021;49(5): 49–56. 10.15586/aei.v49i5.445.

27. Martinez-Jaramillo C, Trujillo-Vargas CM. Dissecting the localization of lipopolysaccharide-responsive and beige-like anchor protein (LRBA) in the endomembrane system. Allergol Immunopathol (Madr). 2020;48(1):8–17. 10.1016/j.aller.2019.07.011.

28. Forman HJ, Zhang H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20(9):689–709. 10.1038/s41573-021-00233-1.

29. Mizushima N, Levine B. Autophagy in human diseases. N Engl J Med. 2020;383(16):1564–76. 10.1056/NEJMra2022774.

30. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration—Emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38(7):450–71. 10.1080/07853890600946724.

31. Khoo HE, Ng HS, Yap WS, Goh HJH, Yim HS. Nutrients for prevention of macular degeneration and eye-related diseases. Antioxidants (Basel). 2019;8(4):85. 10.3390/antiox8040085.

32. Hwang N, Kwon MY, Woo JM, Chung SW. Oxidative stress-induced pentraxin 3 expression human retinal pigment epithelial cells is involved in the pathogenesis of age-related macular degeneration. Int J Mol Sci. 2019;20(23):6028. 10.3390/ijms20236028. PMid: 31795454.

33. Lazzarini R, Nicolai M, Lucarini G, Pirani V, Mariotti C, Bracci M, et al. Oxidative stress in retinal pigment epithelium impairs stem cells: A vicious cycle in age-related macular degeneration. Mol Cell Biochem. 2022;477(1):67–77. 10.1007/s11010-021-04258-3..

34. Mitter SK, Song C, Qi X, Mao H, Rao H, Akin D, et al. Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy.2014;10(11):1989–2005.10.4161/auto.36184.

35. Hyttinen J, Blasiak J, Tavi P, Kaarniranta K. Therapeutic potential of PGC-1α in age-related macular degeneration (AMD)—The involvement of mitochondrial quality control, autophagy, and antioxidant response. Expert Opin Ther Targets. 2021;25(9):773–85. 10.1080/14728222.2021.1991913.

36. Ma D, Zhao Y, She J, Zhu Y, Zhao Y, Liu L, et al. NLRX1 alleviates lipopolysaccharide-induced apoptosis and inflammation in chondrocytes by suppressing the activation of NF-κB signaling. Int Immunopharmacol. 2019;71:7–13. 10.1016/j.intimp.2019.03.001.

37. Leber A, Hontecillas R, Zoccoli-Rodriguez V, Bienert C, Chauhan J, Bassaganya-Riera J. Activation of NLRX1 by NX-13 alleviates inflammatory bowel disease through immunometabolic mechanisms in CD4(+) T cells. J Immunol. 2019;203(12): 3407–15. 10.4049/jimmunol.1900364.

38. Aikawa C, Nakajima S, Karimine M, Nozawa T, Minowa-Nozawa A, Toh H, et al. NLRX1 negatively regulates group A streptococcus invasion and autophagy induction by interacting with the Beclin 1-UVRAG complex. Front Cell Infect Microbiol. 2018;8:403. 10.3389/fcimb.2018.00403.

39. Guo H, Callaway JB, Ting JP. Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–87. 10.1038/nm.3893.

40. Pinkerton JW, Kim RY, Robertson AAB, Hirota JA, Wood LG, Knight DA, et al. Inflammasomes in the lung. Mol Immunol. 2017;86:44–55. 10.1016/j.molimm.2017.01.014.